Gene · 7732
Papers1,998
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,998
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional characterization of C21ORF2 association with the NEK1 kinase mutated in human in diseases. | Life Sci Alliance | 2023 | 37188479 | PubTator, text mining | PubMed |
| Astrocytic control of extracellular GABA drives circadian timekeeping in the suprachiasmatic nucleus. | Proc Natl Acad Sci U S A | 2023 | 37186824 | PubTator, text mining | PubMed |
| Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation. | Sci Rep | 2023 | 37169829 | PubTator, text mining | PubMed |
| CRISPR-Cas9 knockout screen identifies novel treatment targets in childhood high-grade glioma. | Clin Epigenetics | 2023 | 37161535 | PubTator, text mining | PubMed |
| Lysine deserts prevent adventitious ubiquitylation of ubiquitin-proteasome components. | Cell Mol Life Sci | 2023 | 37160462 | PubTator, text mining | PubMed |
| Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineering. | Nucleic Acids Res | 2023 | 37158248 | PubTator, text mining | PubMed |
| An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus. | Nat Cell Biol | 2023 | 37156909 | PubTator, text mining | PubMed |
| Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells. | PLoS One | 2023 | 37146009 | PubTator, text mining | PubMed |
| Translational fidelity screens in mammalian cells reveal eIF3 and eIF4G2 as regulators of start codon selectivity. | Nucleic Acids Res | 2023 | 37144468 | PubTator, text mining | PubMed |
| Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas. | Cancer Discov | 2023 | 37141112 | PubTator, text mining | PubMed |
Performance of Body Adiposity Index and Relative Fat Mass in Predicting Bioelectric Impedance Analysis-Derived Body Fat Percentage: A Cross-Sectional Study among Patients with Type 2 Diabetes in the Ho Municipality, Ghana. | Biomed Res Int | 2023 | 37101689 | PubTator, text mining | PubMed |
| Alternative CDC20 translational isoforms tune mitotic arrest duration. | Nature | 2023 | 37100900 | PubTator, text mining | PubMed |
| Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e. | Adv Sci (Weinh) | 2023 | 37098587 | PubTator, text mining | PubMed |
| The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein. | iScience | 2023 | 37095859 | PubTator, text mining | PubMed |
| Phase-separated DropCRISPRa platform for efficient gene activation in mammalian cells and mice. | Nucleic Acids Res | 2023 | 37094074 | PubTator, text mining | PubMed |
| Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6. | Nat Commun | 2023 | 37085489 | PubTator, text mining | PubMed |
| A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells. | Nucleic Acids Res | 2023 | 37070192 | PubTator, text mining | PubMed |
| Ankyrin-B is lipid-modified by S-palmitoylation to promote dendritic membrane scaffolding of voltage-gated sodium channel NaV1.2 in neurons. | Front Physiol | 2023 | 37064897 | PubTator, text mining | PubMed |
| Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia. | Cell Rep | 2023 | 37060567 | PubTator, text mining | PubMed |
| In mitosis integrins reduce adhesion to extracellular matrix and strengthen adhesion to adjacent cells. | Nat Commun | 2023 | 37059721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7732/papers?page=17